HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Left ventricular remodeling and function after transapical versus transfemoral transcatheter aortic valve replacement.

AbstractBACKGROUND:
The effect of utilizing transapical (TA) access for transcatheter aortic valve replacement (TAVR) on cardiac function has not been well studied.
AIMS:
The aim of this retrospective study is to determine the direct effects of TA access for TAVR on myocardial function parameters and their correlation with 4-year survival.
METHODS:
Three hundred and thirty propensity matched patients, who underwent TAVR using Sapien valve (Edwards Lifesciences Corp, Irvine, CA) between February 15, 2012 and June 17, 2016 (115 TA and 115 transfemoral [TF] routes) were studied. The pre- and 1 month post-TAVR echocardiographic features of both groups were compared. The 4-year survival in both groups was analyzed.
RESULTS:
Baseline clinical characteristics, diastolic function parameters, left ventricular (LV) chamber size, and ejection fraction were similar between matched TA and TF groups. At 1 month following TAVR, there was a significant increase in stroke volume index (SVI) in both TA (mean increase 7 cm3 /m2 ; P = 0.03) and TF groups (mean increase 7 cm3 /m2 ; P < 0.001). Left ventricular ejection fraction (LVEF) significantly increased post TF TAVR (mean increase 2%; P = 0.008), but no significant increase was observed post TA TAVR (mean increase 1%; P = 0.27). Both groups had significant improvement in aortic valve (AV) hemodynamics post-TAVR (P < 0.001). Overall, there were no significant differences in the mean change of SVI, LVEF, or left ventricular end diastolic dimensions (LVEDDs) post TA versus TF TAVR. There was no significant difference in 4-year survival in the TF compared to TA group (49% vs 50%, P = 0.43).
CONCLUSION:
Both TA and TF TAVR were equally associated with favorable changes in LV SVI and AV hemodynamics in 30 days. TA TAVR patients had similar 4 year survival to propensity matched TF TAVR; therefore, TA TAVR remains an acceptable alternative access route in patients not amenable to TF TAVR.
AuthorsMohammed A Al-Hijji, Chad J Zack, Vuyisile T Nkomo, Sorin V Pislaru, Patricia A Pellikka, Guy S Reeder, Kevin L Greason, Charanjit S Rihal, Mackram F Eleid
JournalCatheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (Catheter Cardiovasc Interv) Vol. 94 Issue 5 Pg. 738-744 (Nov 01 2019) ISSN: 1522-726X [Electronic] United States
PMID30688003 (Publication Type: Comparative Study, Journal Article)
Copyright© 2019 Wiley Periodicals, Inc.
Topics
  • Aged
  • Aged, 80 and over
  • Aortic Valve (diagnostic imaging, physiopathology, surgery)
  • Aortic Valve Stenosis (diagnostic imaging, mortality, physiopathology, surgery)
  • Cardiac Catheterization (adverse effects, mortality)
  • Catheterization, Peripheral (adverse effects, mortality)
  • Female
  • Femoral Artery
  • Hemodynamics
  • Humans
  • Male
  • Punctures
  • Retrospective Studies
  • Time Factors
  • Transcatheter Aortic Valve Replacement (adverse effects, instrumentation, mortality)
  • Treatment Outcome
  • Ventricular Function, Left
  • Ventricular Remodeling

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: